83.1% of males survive myeloma for at least one year. This falls to 52.6% surviving for five years or more, as shown by age-standardised net survival for patients diagnosed with myeloma during 2013-2017 in England. Survival for females at one year is 82.1% and falls to 51.8% surviving for at least five years. Survival for females is similar to than for males at one year, and similar to at five years.
Myeloma Age-Standardised One-, Five- and Ten-Year Net Survival, Adults (Aged 15-99), England, 2013-2017
Myeloma survival continues to fall beyond five years after diagnosis. 28.8% of males and 29.5% of females are predicted to survive their disease for ten years or more, as shown by age-standardised net survival for patients diagnosed with myeloma during 2013-2017 in England.
- Office for National Statistics, Cancer survival by stage at diagnosis for England, 2019.
About this data
Data is for England, 2013 - 2017, ICD-10 C90.
Survival statistics give an overall picture of survival and the survival time experienced by an individual patient may be much higher or lower, depending on specific patient and tumour characteristics.